|
INVS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.73920000015693E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.755670E-03 |
| Normal-vs-Stage2 |
1.848500E-04 |
| Normal-vs-Stage3 |
2.80319989443001E-10 |
| Normal-vs-Stage4 |
2.18030038467987E-10 |
| Stage1-vs-Stage2 |
9.720200E-02 |
| Stage1-vs-Stage3 |
6.00309999999604E-05 |
| Stage1-vs-Stage4 |
1.58858999999012E-05 |
| Stage2-vs-Stage3 |
2.593200E-01 |
| Stage2-vs-Stage4 |
9.124100E-02 |
| Stage3-vs-Stage4 |
4.213400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.68379999837742E-08 |
| Normal-vs-AfricanAmerican |
1.031600E-04 |
| Normal-vs-Asian |
5.149200E-01 |
| Caucasian-vs-AfricanAmerican |
5.551200E-01 |
| Caucasian-vs-Asian |
4.601600E-02 |
| AfricanAmerican-vs-Asian |
3.285600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.19879670027012E-11 |
| Normal-vs-Female |
2.189700E-02 |
| Male-vs-Female |
2.63280000001309E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.239950E-02 |
| Normal-vs-Age(41-60Yrs) |
8.14060000000616E-05 |
| Normal-vs-Age(61-80Yrs) |
1.29349997379791E-09 |
| Normal-vs-Age(81-100Yrs) |
2.937500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.172400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.271000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.629200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.134100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.042400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.990600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.409800E-01 |
| Normal-vs-Grade 2 |
1.663310E-03 |
| Normal-vs-Grade 3 |
6.89000001496964E-09 |
| Normal-vs-Grade 4 |
1.7714718580919E-12 |
| Grade 1-vs-Grade 2 |
3.691900E-02 |
| Grade 1-vs-Grade 3 |
9.786900E-04 |
| Grade 1-vs-Grade 4 |
3.72869999987202E-07 |
| Grade 2-vs-Grade 3 |
2.344900E-03 |
| Grade 2-vs-Grade 4 |
2.27130000363118E-08 |
| Grade 3-vs-Grade 4 |
3.682300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.510600E-01 |
| Normal-vs-ccB subtype |
1.67765801251107E-12 |
| ccA subtype-vs-ccB subtype |
1.63158375698913E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.36460000002658E-06 |
| Normal-vs-N1 |
4.400400E-03 |
| N0-vs-N1 |
1.885200E-01 |
|
|
